Use of convalescent plasma in patients hospitalised with COVID-19
This webinar will be shared via zoom, please register
Plasma from patients who have recovered from SARS-CoV-2 infection (convalescent plasma) contains antibodies that can bind to and neutralise the virus. Infusion of convalescent plasma containing high concentrations of neutralising antibody may theoretically accelerate clearance of the virus and clinical improvement. Although convalescent plasma has been widely used in patients admitted to hospital with COVID-19, data from randomised controlled trials in this patient group have, until recently, been limited. This webinar provides evidence from randomised controlled trials of the safety and efficacy of convalescent plasma in patients hospitalised for COVID-19. Join an extraordinary panel of leading international experts, including Professor Peter Horby talking about the RECOVERY Trial, to hear the latest research and have the opportunity to ask questions.
Date: 10 June 2021, 9:00 (Thursday, 7th week, Trinity 2021)
Venue: Venue to be announced
Speakers: Professor Peter Horby (University of Oxford), Soumyadeep Bhaumik (International Public Health Specialist, George Institute for Global Health), Aparna Mukherjee (Senior Scientist, Indian Council of Medical Research)
Organising department: Centre for Tropical Medicine and Global Health
Organiser: Nina Jamieson (University of Oxford)
Organiser contact email address:
Part of: Tropical Medicine Seminars
Booking required?: Required
Booking url:
Audience: Public
Editor: Claire Escher Kessler